Dr Reddy's Laboratories Ltd DRREDDY-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:23 PM IST
4,376.65quote price arrow down-20.90 (-0.48%)
Volume
267,773
52 week range
3,654.00 - 5,077.00
Loading...
  • Open4,390.00
  • Day High4,408.55
  • Day Low4,372.00
  • Prev Close4,397.55
  • 52 Week High5,077.00
  • 52 Week High Date10/04/21
  • 52 Week Low3,654.00
  • 52 Week Low Date03/04/22

Key Stats

  • Market Cap8,830.06M
  • Shares Out165.98M
  • 10 Day Average Volume515,378.33
  • Dividend30.00
  • Dividend Yield0.69%
  • Beta-
  • YTD % Change-10.78

KEY STATS

  • Open4,390.00
  • Day High4,408.55
  • Day Low4,372.00
  • Prev Close4,397.55
  • 52 Week High5,077.00
  • 52 Week High Date10/04/21
  • 52 Week Low3,654.00
  • 52 Week Low Date03/04/22
  • Market Cap8,830.06M
  • Shares Out165.98M
  • 10 Day Average Volume515,378.33
  • Dividend30.00
  • Dividend Yield0.69%
  • Beta-
  • YTD % Change-10.78

RATIOS/PROFITABILITY

  • EPS (TTM)180.26
  • P/E (TTM)24.28
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date07/11/2022
  • Div Amount30.00
  • Split Date-
  • Split Factor-

Latest On Dr Reddy's Laboratories Ltd

 

Profile

MORE
Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI)...
K. Satish Reddy
Chairman of the Board
Erez Israeli
Chief Executive Officer
Parag Agarwal
Chief Financial Officer
Mukesh Rathi
Chief Digital and Information Officer
Address
8-2-337,, Road No.3 Banjara Hills
Hyderabad
500034
India